Adrian Krainer, laureate of 2021 Wolf Prize in Medicine for his fundamental mechanistic discoveries on RNA splicing leading to a world's first treatment for spinal muscular atrophy (SMA).
Professor Adrian Krainer and his collaborator Paola Haeger Soto, an associate professor were awarded a $200,000 Innovation Fund grant to investigate the biology behind fetal alcohol syndrome.
The Pew Innovation Fund encourages cross-disciplinary collaborations to tackle biological questions in new ways.
Krainer’s and collaborators’ work has already led to the development of one therapy to treat a splicing disease—Spinraza®—to treat the neurodegenerative disease spinal muscular atrophy. He is hoping to apply a similar research methodology for treating fetal alcohol syndrome.